Author

Zhan Yao

Institution: Loxo Oncology at Lilly (United States)

Observed institutions: Memorial Sloan Kettering Cancer Center, Loxo Oncology at Lilly (United States)

OpenAlex ID: A5042859991

Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

2015 · Benjamin Heath Durham, Eli L. Diamond, et al. · Blood · 10

Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma

2024 · Michelangelo Marasco, Dinesh Kumar, et al. · Cell Reports Medicine · 4

Abstract 4078: Tumors with class 3 BRAF mutants are sensitive to the inhibition of activated RAS

2017 · Zhan Yao, Rona Yaeger, et al. · Cancer Research

Works count: 4

Citation count: 14

H-index: 2

I10-index: 1